Yoga for Type 2 Diabetes

Therapuetic Areas:Endocrinology
Age Range:18 - Any
Start Date:September 2015
End Date:September 2017

Use our guide to learn which trials are right for you!

Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation

This study will examine the feasibility and acceptability of a twice weekly yoga program for
adults with type 2 diabetes. Changes in perceived stress, salivary cortisol, and HbA1c will
also be examined.

The purpose of the current proposal is to test a yoga intervention for adults with T2DM and
to gather data on the feasibility and acceptability of yoga compared to a contact control for
glycemic control. The investigators will conduct a pilot randomized controlled study with
participants randomly assigned to 1) Yoga intervention, or 2) A standard exercise (SE) group
program (comparison-control). Focus groups will be conducted with participants at the end of
the intervention to identify facilitators and barriers to yoga practice and to examine their
perceptions and beliefs about yoga and its relationship to stress and diabetes management.
The investigators will explore the effect of yoga on stress (biomarker = salivary cortisol)
that may act as a mechanism of action underlying the efficacy of yoga for improved glycemic
control. The investigators will also measure HbA1c levels, fasting and postprandial plasma
glucose at baseline, end of treatment (12-weeks), 6- and 9-month follow-ups. Study
feasibility and acceptability will be assessed using participant recruitment, attendance and
retention rates, and compliance with study protocols and satisfaction with the program.
Participants will also attend a focus-group discussion of the program at the end of
treatment. Results from this study will provide scientific basis for a future larger clinical
trial. Yoga, if found to offer advantages for glycemic control, can have potential for high
impact on current practices of diabetes management.

Inclusion Criteria:

- Type 2 diabetes for more than 6 months

- HbA1c > 6.5

- Body Mass Index < 42

Exclusion Criteria:

- Serious co-morbid condition (e.g. uncontrolled hypertension, glaucoma, heart failure)

- Complications of diabetes (e.g. diabetic retinopathy, neuropathy, nephropathy)

- Serious psychiatric disorder (e.g. psychosis, major depression, panic attacks,
suicidality, or substance dependence)

- Body Mass Index of 42 or greater

- Pregnancy or planned pregnancy
We found this trial at
164 Summit Ave
Providence, Rhode Island 02906
(401) 793-2500
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
Providence, RI
Click here to add this to my saved trials